Regencell Bioscience Holdings Limited
NASDAQ: RGC
Healthcare
Drug Manufacturers - Specialty & Generic
Rank
#3156
Market Cap
5.11 B
Volume
34,859
Price
393
Change (%)
2.24%
Country or region
Hong Kong
Hong Kong
Regencell Bioscience Holdings Limited's latest marketcap:
5.11 B
As of 05/18/2025, Regencell Bioscience Holdings Limited's market capitalization has reached $5.11 B. According to our data, Regencell Bioscience Holdings Limited is the 3156th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 5.11 B |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -4,301,837 |
| Shares Out | 13.01 M |
| EPS (ttm) | -0.33 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 06/20/2025 |
Market Cap Chart
Data Updated: 05/18/2025
Regencell Bioscience Holdings Limited's yearly market capitalization.
Regencell Bioscience Holdings Limited has seen its market value grow from $413.00 M to $5.11 B since 2021, representing a total increase of 1,138.26% and an annual compound growth rate (CAGR) of 110.57%.
| Date | Market Cap | Change (%) |
|---|---|---|
| 05/18/2025 | $5.11 B | 7309.11% |
| 12/31/2024 | $64.28 M | -52.95% |
| 12/29/2023 | $136.64 M | -62.35% |
| 12/29/2022 | $362.93 M | -12.12% |
| 12/31/2021 | $413.00 M |
Company Profile
Frequently Asked Questions
As of 05/18/2025, Regencell Bioscience Holdings Limited (including the parent company, if applicable) has an estimated market capitalization of $5.11 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Regencell Bioscience Holdings Limited global market capitalization ranking is approximately 3156 as of 05/18/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
| Country or region | Hong Kong |
| Founded | 2014 |
| IPO Date | 07/16/2021 |
| Employees | 12 |
| CEO | |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Address | |
| Website |
